000 | 01965 a2200553 4500 | ||
---|---|---|---|
005 | 20250515230515.0 | ||
264 | 0 | _c20100830 | |
008 | 201008s 0 0 eng d | ||
022 | _a1521-7035 | ||
024 | 7 |
_a10.1016/j.clim.2010.04.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBontkes, Hetty J | |
245 | 0 | 0 |
_aAttenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. _h[electronic resource] |
260 |
_bClinical immunology (Orlando, Fla.) _cSep 2010 |
||
300 |
_a364-74 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntigen Presentation |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aClonal Anergy |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGalactosylceramides _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypersensitivity, Delayed |
650 | 0 | 4 |
_aImmunization _xmethods |
650 | 0 | 4 | _aInjections, Intradermal |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNatural Killer T-Cells _xcytology |
650 | 0 | 4 |
_aOvalbumin _xadministration & dosage |
700 | 1 | _aMoreno, María | |
700 | 1 | _aHangalapura, Basav | |
700 | 1 | _aLindenberg, Jelle J | |
700 | 1 | _ade Groot, Jan | |
700 | 1 | _aLougheed, Sinéad | |
700 | 1 | _avan der Vliet, Hans J J | |
700 | 1 | _avan den Eertwegh, Alfons J M | |
700 | 1 | _ade Gruijl, Tanja D | |
700 | 1 | _avon Blomberg, B Mary E | |
700 | 1 | _aScheper, Rik J | |
773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 136 _gno. 3 _gp. 364-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clim.2010.04.019 _zAvailable from publisher's website |
999 |
_c19919014 _d19919014 |